Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLCHIP
DRKS00037089Phase 2Completed
- Sponsor
- Deutsches Herzzentrum München
- Start
- Jun 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of colchicine in coronary arteriosclerosis and clonal haematopoiesis of indeterminate potential (CHIP) (2 arms), sponsored by Deutsches Herzzentrum München. Started Jun 2025; status: completed.
02
Drugs
colchicine
03
Conditions
coronary arteriosclerosisclonal haematopoiesis of indeterminate potential (CHIP)
Beyond the preview
Go deeper on DRKS00037089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00037089.